
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue
Recently announced collaboration between Viome and Henry Schein allows dentists to offer sample collection for Viome’s assay to patients